Error: Could not add to watchlist. X

Carnegie Fund II - Biotechnology Sub-Fund

+ Watchlist
CARBIOA:LX
35.30
EUR
As of 00:00:00 ET on 08/28/2015.
Fund Type
SICAV
52Wk Range
26.93 - 41.76
1 Yr Return
35.35%
YTD Return
12.74%
52Wk Range
26.93 - 41.76
1 Yr Return
35.35%
YTD Return
12.74%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 08/28/2015)
35.3
Total Assets (m EUR) (on 07/31/2015)
40.243
Inception Date
10/10/2000
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
ULF ARVIDSSON
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.10%
Expense Ratio
1.10%
Top Fund Holdings
Name Position Value % of Fund
Celgene Corp 29.30 k 3.47 m 8.62
Gilead Sciences Inc 29.80 k 3.15 m 7.83
Vertex Pharmaceuticals Inc 23.30 k 2.80 m 6.95
Biogen Inc 8.43 k 2.38 m 5.91
BioMarin Pharmaceutical Inc 15.41 k 2.02 m 5.02
Regeneron Pharmaceuticals Inc 3.45 k 1.72 m 4.28
Cempra Inc 44.20 k 1.70 m 4.23
Medivation Inc 16.23 k 1.57 m 3.90
Tetraphase Pharmaceuticals Inc 33.90 k 1.44 m 3.59
Jazz Pharmaceuticals PLC 8.22 k 1.41 m 3.51
Profile
Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.
ADDRESS
c/o Carnergie Fund Services SA
P.O. BOX 1141
L-1011 Luxembourg
Luxembourg
PHONE
352-40-40-30-1